Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Measurement of Alanine Aminotransaminase (ALT) Following Initiation of Antidiabetic Agents in Patients With Type 2 Diabetes in a Real-world Clinical Setting: a Retrospective Cohort Study

NCT03233178 is registered in ClinicalTrials.gov with LMC Diabetes & Endocrinology Ltd. as lead sponsor.

NCT NCT03233178
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03233178 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Measurement of Alanine Aminotransaminase (ALT) Following Initiation of Antidiabetic Agents in Patients With Type 2 Diabetes in a Real-world Clinical Setting: a Retrospective Cohort Study
Lead sponsor
LMC Diabetes & Endocrinology Ltd.
Phase
Observational
Overall status
Completed
Start date
January 31, 2017
Completion date
June 30, 2017
Enrollment
4,000 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fatty liver, nafld, t2dm (type 2 diabetes mellitus)